SI-BONE, Inc. (SIBN) income statement
SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3046% above fair value
$23.54+0.38 (+1.64%)
Close on Nov 18, 2026Market cap $1.06BP/E –Yield 0.00%
SI-BONE, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 79.5%
- Operating margin
- -8.3%
- Net margin
- -6.9%
- Return on equity, FY2025
- -11.0%
Financial strength
- Current ratio
- 9.15
- Debt to equity
- 0.20
- Debt to assets
- 14.3%
- Cash to current liabilities
- 137.8%
Valuation
- P/E ratio
- –
- Price to sales
- 4.94
- Price to book
- 5.79
- Dividend yield
- 0.00%
See a number that looks wrong?